list glp 1 medications GLP-1 Drug Comparison in Diabetes and Obesity Treatment GLP-1 Agonists - Endocrinology Advisor

"GI AEs typically occur during initiation and uptitration, appearing as transient, mild-to-moderate symptoms." Laura Schalliol, PharmD, BCACP, BCGP, Professor of Pharmacy Practice In fact, 94% of adverse events reported in major clinical trials were mild or moderate in severity

Move to slide five

Excessive gluconeogenesis means your body is producing glucose it doesnt need and cant use

This product has really started to make changes in my child's overall demeanor and wellness

In patients with obesity and T2D, GLP-1RA therapy reduces the levels of inflammatory cytokines (TNF-, IL-1 and IL-6) and the macrophage activation marker soluble CD163, while increasing anti-inflammatory adiponectin (131)